Jay Hinton

@jayhinton.bsky.social

Salmonella admirer & Prof of Microbiology - Working on Salmonella bloodstream infections (iNTS) in sub- Saharan Africa context. Functional genomics. T1D.

New preprint in the lab! "Single-cell metabolomics reveals infection-specific metabolic reprogramming of human macrophages". Led by Paula Martínez, with @cbuch.bsky.social , Sandrine Aros and @jytinevez.bsky.social How does Legionella pneumophila reshape host metabolism at the single-cell scale? 🧵👇

Bild
bioRxiv Microbiology@biorxiv-microbiol.bsky.social · last mo.

Single-cell metabolomics reveals infection-specific metabolic reprogramming of human macrophages https://www.biorxiv.org/content/10.64898/2026.09.03.749052v1

We are advertising an exciting PhD opportunity based at Newcastle University. You’ll use epidemiological and genomic data to characterise Campylobacter burden… and work with me on some cool datasets! Deadline: 28th July 2026 - NB UK Students only due to funding restrictions. Don’t miss out!

NIHR PhD Studentship: Modernising Campylobacter burden assessment using integrated genomics, symptoms and surveillance data at Newcastle University on FindAPhD.com

PhD Project - NIHR PhD Studentship: Modernising Campylobacter burden assessment using integrated genomics, symptoms and surveillance data at Newcastle University, listed on FindAPhD.com

findaphd.com

This is awful to hear, describing how Sean Eddy (HMMER, infernal, pfam, rfam) has been defunded. The letter said his work "had been determined to be of absolutely no value to the US taxpayer, and therefore it was being specifically terminated," www.npr.org/2026/05/21/n...

Researchers say the Trump administration is finding new ways to punish science

Even with federal grants largely restored, scientists say the Trump administration is still preventing those funds from reaching them. The consequences, they say, are already becoming clear.

npr.org

"An email from NIH’s National Institute of General Medical Sciences (NIGMS) to research-center grantees, seen by Science, requires their institutions to promise that U.S. authors of papers NIH has flagged because of foreign co-authors will not collaborate with them in the future."

Carl T. Bergstrom@carlbergstrom.com · 5mo ago

“Units of the NIH are privately directing grantees to request permission in advance for any co-authorship with a scholar affiliated with a foreign institution, even if all the work was done in the United States.” Grantees also told to remove papers with foreign authors from progress reports.

There’s a LOT going on as researchers and public health experts race to respond to the Ebola Bundibugyo outbreak in DRC and Uganda before it grows bigger. Some really important questions still open, but also a few answers coming into view🧪 My overview in @science.org is here (and thread coming):

Scientists play catch-up to startling Ebola outbreak

Testing, sequencing, and clinical trial efforts spring to life as Bundibugyo virus spreads

science.org

BBSRC Early Independence Fellowships had an Outline stage this year to try help with amount of peer review. Turns out they received 586 applications, a 110% increase on 2025, and only typically fund 15 a year. They are cancelling this stage and going straight to full app with an institutional sift.

Pathogen genomics is increasingly being implemented in clinical microbiology. Discover the factors that represent barriers to, and potential enablers of, this implementation, including the availability of funding and genomics-trained staff. #ClinMicroRev: asm.social/2VH

Applications of genomics in clinical microbiology.

Bacteria have been fighting off viruses using a huge arsenal of molecular weaponry that scientists did not know about — until now. Researchers have identified proteins that could lead to virus-fighting drugs and technologies. go.nature.com/4dqQnXI

‘Treasure trove’ of antiviral proteins could inspire powerful molecular tools

Two research teams mined genomic data from bacteria to create databases containing thousands of antiviral defence proteins that could inspire powerful biotechnologies.

go.nature.com